Current role
Biotechnology · Healthcare
Board Member
2025-05-15–present
Amrit Ray, M.D.
Board Member
Ultragenyx Pharmaceutical Inc. (RARE)Equibles does not estimate personal net worth.
Get an email with a short summary when Ultragenyx Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.
Get RARE alertsAbout Amrit Ray, M.D.
Amrit Ray, M.D. is recorded as Board Member at Ultragenyx Pharmaceutical Inc. (RARE) since May 15, 2025. Ultragenyx Pharmaceutical Inc. reported in an 8-K filed May 19, 2025 that Amrit Ray, M.D. was appointed Class III director, effective May 15, 2025. Ultragenyx Pharmaceutical Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ultragenyx Pharmaceutical Inc. includes Emil D. Kakkis (CEO and Board Member), Emil Kakkis (CEO and Board Member), Howard Horn (CFO) and 7 others.
“At the Annual Meeting, the Company's stockholders elected the Class III director nominees below to the Company's Board of Directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected.”
Affiliation history
-
Current
2025-05-15–present
Company network
Leadership on record at Ultragenyx Pharmaceutical Inc.
- Emil D. Kakkis CEO, Board Member
- Emil Kakkis CEO, Board Member
- Howard Horn CFO
- Eric Crombez, M.D. CTO
- Karah Parschauer General Counsel
- Clay B. Siegall Board Member
- Continuing Directors Board Member
- Corazon (Corsee) D. Sanders, Ph.D. Board Member
- Corsee Sanders, Ph.D. Board Member
- Daniel G. Welch Board Member